Overview
Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model
Status:
Recruiting
Recruiting
Trial end date:
2022-11-01
2022-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will assess the safety and antiviral activity of AT-752 in healthy subjects in a Dengue Human Challenge ModelPhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Criteria
Inclusion Criteria:- Must agree to use protocol-specified methods of contraception
- Negative pregnancy test
- Willing to comply with the study requirements and to provide written informed consent
Exclusion Criteria:
- Pregnant or breastfeeding
- Abuse of drugs
- Other clinically significant medical conditions